TGA Approval

KAVIGALE, sipavibart, 300 mg in 2 mL (150 mg/mL), Solution for injection/infusion vial. (459773)

ARTG ID

459773

ARTG Name

KAVIGALE, sipavibart, 300 mg in 2 mL (150 mg/mL), Solution for injection/infusion vial.

Sponsor

AstraZeneca Pty Ltd

ARTG Date

May 22, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ASTRAZENECA PTY LTD

Ingredient Name

sipavibart

Empowering clinical research with data-driven insights and AI-powered tools.